Pillstats
Rx only · Film · Oral

Clobazam

Brands: Sympazan · Clobazam

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US3 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)21241
US makers1 labelers
Packages3
DEA / ScheduleCIV

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$10.98$21.96$32.94$43.93Dec 2025Feb 2026Apr 2026
$38.196
Latest avg · Apr 1, 2026
+2%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

9721.9K2.9K3.9K2025 Q12025 Q22025 Q32025 Q42026 Q1
3.1K
Rx · 2026 Q1
200K
Units dispensed
+3%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Aquestive Therapeuticsunknown3SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.